The key partners in the development and implementation of CMIRPS are
ISMP Canada, Canadian Institute for Health Information (CIHI), and Health Canada.
In the fall of 2000, an invitational workshop was co-hosted by the Canadian Society of
Hospital Pharmacists (CSHP) and Health Canada’s Bureau of Licensed Product Assessment (BLPA)
to address a number of key questions related to medication incident reporting and prevention. The
workshop led to the creation of a national coalition of stakeholders – the Canadian
Coalition on Medication Incident Reporting and Prevention (CCMIRP). This coalition
led the creation of a business plan for the development and implementation of a national
medication incident reporting and prevention system.
In the fall of 2003, funding for the Canadian Medication Incident Reporting and Prevention
System (CMIRPS) was secured. Funding for the CMIRPS is being made available through the signing of
Contribution Agreements between Health Canada and CIHI, and between Health Canada and ISMP Canada.
The purposes of the CMIRPS program are to:
- Coordinate the capture, analysis and dissemination of information on medication incidents;
- Enhance the safety of the medication use system for Canadians; and
- Support the effective use of resources through the reduction of potential or actual harm caused by preventable medication incidents.
The goals of the CMIRPS information system are to:
- Collect data on medication incidents;
- Facilitate the implementation of reporting of medication incidents;
- Facilitate the development and dissemination of timely, targeted information designed to reduce the risk of medication incidents (e.g. ISMP Canada Safety Bulletins); and
- Facilitate the development and dissemination of information on best practices in safe medication use systems.
|
ISMP Canada has made a variety of reporting mechanisms available to individual practitioners and the general public, including telephone or web portal electronic submission. Reports may be submitted anonymously if preferred.


ISMP Canada's consumer-focused website, www.SafeMedicationUse.ca, is part of the Canadian Medication Incident Reporting and Prevention System (CMIRPS), a Canadian initiative to prevent harmful medication incidents. SafeMedicationUse.ca provides a better way for consumers to report medication incidents and to get information about using medication safely.
Contact us by sending an email message to cmirps@ismp-canada.org or call 416-733-3131 or toll free: 1-866-544-7672.
|